1. Introduction
===============

Nitric oxide (NO) is a diffusible highly reactive gas produced by the enzymatic conversion of L-arginine by nitric oxide synthases (NOS). NO possesses an unusually large repertory of physiological functions and it is probably one of the oldest bioregulatory systems controlling metazoan physiology [@B1]. In addition to the well-documented roles of NO in vertebrates (reviewed in [@B2]), many studies also support the functional relevance of NO in invertebrates [@B3]-[@B8]. Classically, NO action had been associated with the cGMP signalling pathway. However, the current picture points to additional mechanisms for NO bioactivity such as S-nitrosylation of cysteine thiols (SNO) [@B2], [@B9], a post-translational protein modification that regulates the activity of metabolic enzymes, structural proteins or transcription factors [@B10]. Although specific enzymatic mechanisms involved in protein S-nitrosylation have not yet been described, degradation of S-nitrosoglutathione (GSNO) promotes the denitrosylated state and so, GSNO turnover, significantly influences the level of whole-cell S-nitrosylation.

GSNO is mainly degraded by an NADH-dependent S-nitrosoglutathione reductase (GSNOR) activity [@B11], associated to the medium-chain alcohol dehydrogenase class III (MDR-ADH3) enzyme, also known as glutathione-dependent formaldehyde dehydrogenase (FALDH) [@B11]-[@B14]. ADH3 enzymes had been involved in formaldehyde metabolism, oxidising S-hydroxymethylglutathione (HMGSH) to S-formylglutathione [@B15]. However, the high specificity of ADH3 towards GSNO [@B12] and the fact that yeast and mouse ADH3 knockouts devoid of GSNOR activity show a substantial increase of S-nitrosylated proteins [@B9], [@B11] have established a direct relation of ADH3 with NO metabolism.

ADH3 enzymes have been identified in most major life forms, ranging from bacteria to animals. ADH3 is the only member of the MDR-ADH family found in non-vertebrate organisms, and is considered the archetypal form from which multiple gene duplications expanded the vertebrate ADH family into at least eight different classes (ADH1--8) (reviewed in [@B16]). In previous studies, we showed that in contrast to the widespread expression pattern of the vertebrate *Adh3*, the expression of the *Adh3* in non-vertebrate organisms (e.g. arthropods, ascidians and cephalochordates) is restricted to the digestive system [@B17], [@B18]. This finding suggested that the ADH family expansion during early vertebrate evolution was accompanied by a change in the *Adh3* expression pattern, and challenged the role that had been classically attributed to ADH3 as a housekeeping enzyme in charge of formaldehyde elimination [@B18]. In this work, we provide the first evidence that ADH3 might be involved in NO homeostasis in the cephalochordate *Branchiostoma floridae*. Pure preparations of recombinant amphioxus ADH3 showed *in vitro* the ability to reduce GSNO, indeed a better substrate than HMGSH, the intermediate product in formaldehyde metabolism. Moreover, to correlate ADH3 expression with NO production, we have performed immunostaining of NOS in developing larvae, and showed ADH3/NOS co-localization in mid- and hind-gut areas.

2. Materials and Methods
========================

Electrophoresis and enzymatic activity staining of crude extracts
-----------------------------------------------------------------

To detect GSNO reductase and formaldehyde dehydrogenase activities, six amphioxus adults were homogenized in 2 ml of degassed 0.1 M sodium pyrophosfate, 0.1 mM DTT, and centrifuged at 20,000 g for 20 min. Protein concentration of the crude extracts was determined colorimetrically. Enzymatic activity was assessed after electrophoresis on non-denaturing 7.5% polyacrylamide gel. For formaldehyde dehydrogenase activity, gels were incubated in 0.1 M sodium pyrophosphate pH 8.0, 0.5 M KCl, 1 mM reduced glutathione and 5 mM formaldehyde at 37 ºC [@B19]. After 5 minutes, nitroblue tetrazolium and phenazine methosulfate were added at a final concentration of 0.1 mM each. For GSNO reductase activity, gels were incubated in 0.1 M sodium pyrophosphate at pH 7.4 with 2 mM NADH, for 15 min in an ice-bath [@B14]. Excess buffer was drained and gels were covered with filter paper strips soaked in GSNO. After 15 min, the filter paper was removed and the gel was exposed under ultraviolet light to observe the disappearance of the NADH fluorescence.

Expression and purification of recombinant *B. floridae* ADH3
-------------------------------------------------------------

The full-length coding region of *B. floridae Adh3* cDNA [@B17] was PCR amplified with the sense primer 5\'-TT[GGATCC]{.ul}**ATG**GCGGACACTG-3\', which introduces a *Bam*HI restriction site (underlined) next to the ATG (in bold), and the antisense primer 5\'-C[GAATTC]{.ul}TCAGAAGTGGATCAC-3\', which places a *Eco*RI site (underlined) at the 3\'-end. The PCR conditions were as follows: an initial denaturation step at 94ºC for 5 min, followed by 40 cycles at 94ºC for 45 s, 42ºC for 1 min and 72ºC for 2 min and a final extension step at 72ºC for 5 min. The purified fragment was digested with *Bam*HI and *Eco*RI enzymes and cloned into the expression vector pRSETA (Invitrogen), to fuse a polyhistidine tag at the N-terminal of ADH3. The expression of His-ADH3 protein in *E. coli* BL21 (DE3) pLys was induced with 0.1 mM isopropyl-β-D-thiogalactopyranoside for 3 h at 37ºC. Cells were harvested and disrupted by sonication in cold PBS. Protein extracts were collected after centrifugation at 20,000 g for 20 min at 4ºC and His-ADH3 was partially purified with a Talon Metal Affinity Resin following the supplier\'s instructions (BD Biosciences Clontech, USA). Protein recovered after overnight treatment with enterokinase (EKMaxTM Enterokinase; Invitrogen) at 16ºC, was loaded in Superdex200 FPLC column equilibrated with 20 mM TrisHCl pH 8.0. Formaldehyde/GSH activity was tested in the collected fractions. From 500 ml culture, 5 μg of pure ADH3 was obtained with a specific activity with formaldehyde of 4.3 U/mg. Protein concentration was determined colorimetrically and purity was analysed by SDS-PAGE with Coomassie brilliant blue staining. Enzymatic activity of the purified recombinant protein was assayed *in situ* after electrophoresis as described in the previous section.

Kinetic studies
---------------

Formaldehyde dehydrogenase and GSNO reductase activities were tested at 25ºC by monitoring the production of NADH at 340 nm (ε~340~ = 6,22 mM^-1^ cm^-1^) for formaldehyde oxidation or the consumption of NADH and GSNO (ε~340~ = 7,06 mM^-1^ cm^-1^) for GSNO reduction. The formaldehyde dehydrogenase activity was measured at pH 8.0 in 0.1 M sodium pyrophosphate, with S-hydroxymethylglutathione (HMGSH; formed by mixing formaldehyde and glutathione) and NAD^+^. GSNO reductase activity was measured at pH 7.5 in 0.1 M sodium pyrophosphate, with freshly prepared GSNO and NADH. Kinetic constants for NAD^+^ and NADH were determined with 1 mM of glutathione - 1 mM of formaldehyde, and with 0.3 mM of GSNO, respectively. Kinetic constants for HMGSH and GSNO were determined with 2.4 mM NAD^+^ and 0.3 mM NADH, respectively. Kinetic constants were calculated with the non-linear regression program Grafit (version 3.0, Erithacus Software), and expressed as the mean ± SD of at least three independent determinations. Catalytic constant (kcat) values were calculated using the protein molecular mass of 80,000 for the ADH3 dimer.

Amphioxus NOS and phylogenetic analysis
---------------------------------------

A *B. floridae* cDNA-NOS sequence was retrieved from GeneBank, accession number AF396968, and compared with available vertebrate and invertebrate sequences. The following NOS sequences were used in our study: AAK83069 (*Aplysia californica*, California sea hare), O61608 (*Anopheles stephensi*, mosquito), BAB85836 (*Bombix mori*, silk worm), CAB60197 (*Cyprinus carpio*, carp). XP_692103 and NP_571735 (*Danio rerio*, zebrafish), NP_523541 (*Drosophila melanogaster*, fruit fly), NP_990292 and XP_425296 (*Gallus gallus*, chiken), P29474, AAA36375 and P29475 (*Homo sapiens*, human), O61309 (*Lymnaea stagnalis*, great pond snail), O77104 (*Manduca sexta*, tobacco hornworm), P70313, AAM11887 and Q9Z0J4 (*Mus musculus*, mouse), CAC83069 (*Oncorhynchus mykiss*, rainbow trout), NP_068610, BAA07994 and P29476 (*Rattus norvergicus*, rat), Q26240 (*Rhodnius prolixus*, insect), XP_781703 (*Strongylocentrotus purpuratus*, sea urchin), AAM46138 (*Takifugu poecilonotus*). Frog sequences were taken from *Xenopus tropicalis* genome assembly 3.0 (JGI): fgenesh1_pg.C_scaffold \_2000005, estExt_fgenesh1_pg.C_12630001 and fgenesh1_pg.C_scaffold_456000016. Sequences were retrieved and corrected to maximize the similarity with known NOS enzymes.

Protein sequence alignments and a neighbour-joining (NJ) tree were generated with clustalX [@B20] and drawn with the TreeViewPPC program [@B21]. Confidence in each node was assessed by 1000 bootstrap replicates. Maximun likelihood (ML) analysis was performed using the quartet sampling and NJ parameter estimation procedure of TREE-PUZZLE. The N-terminal region of the NOS isozymes (neuronal, inducible and endothelial) are highly variable in length and sequence, and produced unreliable alignments. This region was, therefore, excluded from the phylogenetic analyses and only alignments starting at the oxygenase domain (D352 of human nNOS) were considered.

Western blot and whole-mount immunostaining
-------------------------------------------

For western blot, four *B. floridae* specimens were homogenized in cold PBS, 0.1 mM DTT and centrifuged at 20,000 g for 20 min. 0.5--1.0 mg of soluble protein was resolved on an SDS-PAGE and transferred into a polyvinylidene difluoride (PVDF) membrane. After 1h in blocking buffer (10% fat-free milk in PBS), the membrane was incubated for 1h with a universal anti-NOS antibody (anti-uNOS, Affinity Bioreagents Inc.), at 1:1000 dilution in 0.5% fat-free milk in PBS with 0.05% Tween-20. The anti-uNOS antibody is an affinity purified rabbit anti-NOS directed against a C-terminal epitope (DQKRYHEDIFG) that is highly conserved among the different NOS isoforms in vertebrates, insects and crustaceans [@B22]. Immunoreactive proteins were visualized by ECL Western blotting analysis system (Amersham Biosciences) after incubation for 1h with peroxidase-conjugated goat anti-rabbit secondary antibody used at 1:2000 dilution.

*B. floridae* larvae were collected, fixed, and stored at --20ºC in 70% ethanol. Immunostaining was performed as described [@B23] with minor modifications. Briefly, larvae were incubated in 1 ml ethanol/DMSO (1:1) for 3 min in ice, followed by 15 min at RT after addition of 250 μl Triton X-100. Larvae were rinsed 6 times, 10 min each, in TST (20 mM TrisHCl pH 7.4, 100 mM NaCl and 0.1% Triton X-100) and blocked for 30 min in TSTM (TST containing 5% fat-free milk). The larvae were incubated for 48 h at 4ºC in rabbit anti-uNOS (Affinity Bioreagents Inc.) (dilution 1:100 in TSTM). After rinsed 7 x 20 min, the secondary antibody, donkey anti-rabbit IgG labeled with Rhodamine-red (Jackson Immunoresearch), was added (dilution 1:200) for 48h at 4ºC, and larvae were rinsed again 7 x 20 min. Finally, the samples were mounted using SlowFade light Antifade Kit (Molecular Probes) and observed by confocal microscopy (Leica TCS 4D).

3. Results
==========

GSNO reductase activity of amphioxus ADH3
-----------------------------------------

GSNO reductase activity was assessed spectrophotometrically in amphioxus homogenates, 4.2 x 10^-3^ U/mg. Non-denaturing gel electrophoresis of protein homogenates of whole adult animals showed a very similar banding pattern for GSNO activity and formaldehyde/GSH staining (Figure [1](#F1){ref-type="fig"}, lanes 1 and 2), suggesting that both substrates are metabolised by the same enzyme. To further investigate this possibility, the cDNA of *B. floridae Adh3* was expressed in *E. coli*. The recombinant protein was produced and purified to homogeneity (Figure [1](#F1){ref-type="fig"}, lanes 3, 4 and 5). In the pure preparation, the GSNO reductase and formaldehyde dehydrogenase activities were shown by native gel electrophoresis staining (Figure [1](#F1){ref-type="fig"}, lanes 6 and 7). The specific activities of the purified recombinant ADH3 were quantified by monitoring the absorbance at 340 nm with GSNO (65.6 U/mg ) and HGMGSH (4.3 U/mg) as substrates. The kinetic parameters of *B. floridae* ADH3 (Table[1](#T1){ref-type="table"}) were examined under conditions allowing comparisons with those obtained for other class 3 forms. The Km value for the recombinant *B. floridae* ADH3 in front of HMGSH was essentially the same as that for the native *B. lanceolatum* ADH3 [@B17], but the kcat value (375 min^-1^) was slightly lower than the one previously reported (680 min^-1^). The catalytic efficiency of the recombinant *B. floridae* ADH3 for GSNO reduction was twice that of HMGSH oxidation, indicating the preference for GSNO reduction of the amphioxus enzyme. Yeast and human ADH3 enzymes are also active in HMGSH oxidation and GSNO reduction, with similar reductive *vs*. oxidative ratios than that for amphioxus enzyme: 2.3 and 1.9 times fold, respectively [@B14]. The comparison of human, amphioxus and yeast supports the reported constancy at the functional and structural level of class 3 enzymes [@B24], [@B25].

Amphioxus nitric oxide synthase: phylogeny and immunodetection
--------------------------------------------------------------

To link the GSNOR activity of ADH3 with the production of NO/GSNO, we searched for amphioxus NOS sequences in databases and retrieved a *B. floridae* cDNA (AF396968) with clear homology with vertebrate *Nos* genes. This sequence matched to a unique *Nos* gene that was assembled from the available raw data of the amphioxus genome project. Comparison of the cDNA and the genomic sequences showed minor differences that were corrected to maximize the similarity with known NOS enzymes and allowed us to deduce the gene structure. The *B. floridae Nos* gene was made of 26 exons that expanded over 9.5 kb (data not shown), encoding a 1329 aa protein (Figure [2](#F2){ref-type="fig"}A) equally related with the three --iNOS, eNOS and nNOS-- vertebrate forms. In accordance, in the phylogenetic tree, amphioxus NOS branched outside the clade comprising all vertebrate NOS (Figure [2](#F2){ref-type="fig"}B). This topology would be in agreement with a single *Nos* gene in an ancestral chordate.

NOS protein in adult amphioxus extracts was detected by western blot (Figure [3](#F3){ref-type="fig"}G) using an affinity purified rabbit anti-NOS antibody that specifically recognises a C-terminal epitope, DQKRYHEDIFG, highly conserved among NOS isoforms in vertebrates, insects and crustaceans [@B7], [@B22]. The deduced *B. floridae*sequence for this epitope is: DNNRYHEDIFG. Two immunoreactive bands of approximately 140 kDa and 110 kDa were detected in adult amphioxus extracts (Figure [3](#F3){ref-type="fig"}G). Band multiplicity could correspond to two protein isoforms generated by alternative splicing of NOS transcripts, as reported for mouse, human and *Drosophila* NOS [@B27], [@B28], or to proteolytic cleavage at the N-terminal domain [@B29]. *Whole-mount* immunostaining showed NOS expression also during amphioxus development. While no obvious staining other than background was observed at early developmental stages (data not shown), *B. floridae* 48 h larvae showed a strong signal confined to the mid- and hindgut of the developing intestine and the dorsal region of the club-shaped gland (csg), an enigmatic secretory organ located on the right side of the larval pharynx between the endostyle and the anterior-most pharyngeal gill slit (Figure [3](#F3){ref-type="fig"}, A and B). In the first, the NOS signal was separated by a non-stained segment, which corresponds to the ilio-colon ring, an specialized region with conspicuous cilia that contributes to the food cord passage. Confocal sections revealed a left-right NOS asymmetry in the midgut area (Figure [3](#F3){ref-type="fig"}, C-E), with a triangular region at the left side devoid of signal that corresponds to the lateral ciliated tract. Concerning cgs expression, although the dorsal and ventral cells are not morphologically different, the specific NOS expression to the dorsal area reveals functional differences along the dorsal-ventral axis, as reported for other amphioxus genes, e.g. *Krox* [@B30] and *crabp*[@B31] to the dorsal region, and *maf*[@B31] and *BbPtx* [@B32] to the ventral duct.

4. Discussion
=============

The housekeeping role long attributed to ADH3 as a formaldehyde detoxificating enzyme has been lately challenged after *in situ* analyses and studies on the activity of the enzyme. Concerning expression, the tissue-specificity observed for ADH3 in amphioxus and other invertebrates [@B17], [@B18] was difficult to reconcile with the assumed general cytoprotective role for this enzyme. In relation to the biochemical activity, human and rat ADH3 used substrates other than formaldehyde, such as GSNO [@B12], [@B14], [@B26]. Moreover, we here show a GSNOR activity for the recombinant *B. floridae* ADH3, 2-fold higher that for HMGSH (Table [1](#T1){ref-type="table"}), and preservation of the ADH3 kinetic features during the invertebrate/vertebrate transition, when the ADH family expanded considerably through a series of duplications [@B25]. Based on the strict preservation of the protein structure and the biochemical activities, including those shown in the present study, we assume that the ancestral ADH3 was a multifunctional enzyme, active in HMGSH and GSNO metabolisms.

The biochemical data pointed to a functional role for the cephalochordate ADH3 in the NO homeostasis. To link the ADH3 gut-restricted expression with the NO/GSNO production, we aimed at characterizing the amphioxus *Nos* genes. Surveys of *B. floridae* databases rendered a single-copy *Nos* that showed gut-specific expression in developing larvae. Phylogenetically, the amphioxus NOS protein branched outside the clade that comprised all the vertebrate forms, indicating that the *Nos* duplications took place after the cephalochordate divergence. The topology of the tree also suggested that *Nos* duplicated at least twice during vertebrate evolution: the nNOS enzymes aroused after the first duplicative event, while the iNOS and eNOS were generated after the second. The increase in complexity, probably concomitant with novel areas of NO production, could be linked to the almost generalized ADH3 expression observed in vertebrates [@B18], [@B33] and improved the regulation of NO/GSNO homeostasis.

*In situ* and immunostaining analyses in amphioxus revealed an almost full overlap of the ADH3 and NOS expression patterns and showed the larval intestine as the major organ for NO synthesis and degradation. In vertebrates, the *in vivo* contribution of ADH3 in NO metabolism was established in ADH3 knockout mice, whose major functional alteration was an increase in intracellular SNO-protein levels under basal conditions [@B9], [@B11], effect that was greatly enhanced after endotoxic or bacterial challenge. During host defence responses, vertebrate iNOS is strongly induced [@B34], [@B35] and S-nitrosothiols are currently involved to respond to cryptococcal, salmonella and tuberculous infections [@B36]-[@B38]. NO is also involved in the molluscan [@B39] and *Drosophila*[@B40] defence systems that, in the latter, are thought to originate mainly in the fat body, where *Drosophila*ADH3 is also strongly expressed [@B18]. Overall, the overlapping signals of amphioxus ADH3 and NOS (compare panels A and B with H in Figure [3](#F3){ref-type="fig"}) could account for a GSNO anti-microbial activity in the gut, where the first host-pathogen interaction takes place, and it is therefore prone to bacterial infections.
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Figures and Tables
==================

![Amphioxus total protein homogenate (1.0 mg) resolved on non-denaturing 7.5% polyacrylamide gel electrophoresis and stained for formaldehyde dehydrogenase (lane 1) and GSNO reductase (lane 2) activities. Coomassie stained SDS/PAGE of samples corresponding to the different purification steps of recombinant *B. floridae* ADH3: 40 μg of total protein homogenate (soluble fraction) from an *E. coli* expressing *B. floridae* ADH3 (lane 3); 16 μg of partially purified ADH3 eluted form a Talon Metal Affinity Resin (BD Biosciences Clontech, USA) after enterokinase cleavage (lane 4), and 2.3 μg of pure recombinant enzyme after Superdex200 FPLC column (lane 5). Pure recombinant protein (2.0 μg) was loaded onto non-denaturing 7.5% polyacrylamide gel electrophoresis and stained for formaldehyde dehydrogenase (lane 6) and GSNO reductase (lane 7) activity](ijbsv02p0117g01){#F1}

![(A). Comparison of the deduced amino acid sequences of *B. floriade* NOS (Bf NOS) with human (Hs nNOS, iNOS and eNOS) and *Drosophila* (Dm NOS) forms. Strictly conserved and highly conserved residues (\>60%) are shown in black background, and similar residues in gray. Defined binding domains (as in [@B27]) are overlined in red: cofactor-binding sites for heme (1), calmodulin (2), FMN (3), FAD pyrophosphate (4), FAD isoalloxazine (5), NADPH ribose (6), NADPH adenine (7) and the C-terminal conserved NADPH binding sequence (8). The sequence used for phylogenetic analyses begins at position D352 of human nNOS (\*). (B) Phylogenetic reconstruction of NOS enzymes. Figures at nodes are the scores from 1000-bootstraps resampling of the data (NJ, in black) or quartet puzzling supports values (ML, in red). Ac, *Aplysia californica*, California sea hare; As, *Anopheles stephensi*; Bm, *Bombix mori*; Cc, *Cyprinus carpio*, carp; Dr, *Danio rerio*, zebrafish; Dm, *Drosophila melanogaster*; Gg, *Gallus gallus*; Hs, *Homo sapiens*; Ls, *Lymnaea stagnalis*, great pond snail; Ms, *Manduca sexta*, tobacco hornworm; Mm, *Mus musculus*; Om, *Oncorhynchus mykiss*, rainbow trout; Rr,*Rattus norvergicus*, Rp, *Rhodnius prolixus*, insect; Sp, *Strongylocentrotus purpuratus*, sea urchin, Tp, *Takifugu poecilonotus*; Xt, *Xenopus tropicalis*.](ijbsv02p0117g02){#F2}

![Whole-mount immunostaining of 48 h *B. floridae* larvae with an anti-NOS antibody. (A) Right-sided view. NOS signalling in the developing midgut and hindgut region separated by a non stained area, the ilio-colon ring (arrow), and in the dorsal region of the club-shaped gland (arrowhead). (B) Left-sided view. NOS signalling in the gut shows two non stained regions, which correspond to the ilio-colon ring (arrow) and to the lateral ciliated tract (double arrowhead). (C-E) Magnified view of the confocal sections of the right side, light and left side of the gut, respectively, showing left-right asymmetry in NOS localization. (F) Detail of the NOS staining in the dorsal region of the club-shaped gland (arrowhead). (G)Western blot analysis of amphioxus protein extracts. A total of 1.0 mg of soluble protein extract were resolved by electrophoresis on a SDS-7.5% polyacryla-mide gel, transferred to a polyvinylidene difluoride (PVDF) membrane and incubated with an anti-NOS antibody. Positions of molecular mass markers (in kDa) are shown on the left. (H) *Adh3* expression visualized by whole-mount in situ hybridization as reported in [@B17].](ijbsv02p0117g03){#F3}

###### 

GSNO and HMGSH activities of ADH3.

                                   *B.floridae^a^*   *B. lanceolatum*   *Drosophila*   Rat     Human   Human^1a^   Human^2a^   *S. cerevisiae^a^*
  ----------- -------------------- ----------------- ------------------ -------------- ------- ------- ----------- ----------- --------------------
  **GSNO**    **Km (mM)**          0.056 ± 0.009     \-                 \-             0.028   \-      0.027       0.027       0.15
              **kcat (min^-1^)**   10000 ± 520       \-                 \-             2640    \-      2400        12000       52600
              **kcat/Km**          178800 ± 25100    \-                 \-             94300   \-      90000       444400      350000
  **NADH**    **Km (mM)**          0.045 ± 0.011     \-                 \-             0.024   \-      0.008       0.03        0.13
  **HMGSH**   **Km (mM)**          0.004 ± 0.0006    0.0044             0.006          \-      0.004   0.002       0.0014      0.02
              **kcat (min-^1^)**   375 ± 16          680                960            \-      200     115         320         3100
              **kcat/Km**          87900 ± 9667      150000             160000         \-      50000   58000       229000      155000
  **NAD**     **Km (mM)**          0.008 ± 0.0018    0.011              0.13           \-      0.009   0.007       0.007       0.045

Values are from this work (*B. floridae*ADH3) or from the literature (*B. lanceolatum*, *Drosophila*and Human ([@B17] and references therein); Rat [@B12]; Human^1^ [@B26]; Human^2^ and *S. cerevisiae* [@B14]). ^a^These values are from recombinant expressed enzymes.
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